Rep. Gilbert Cisneros Disclosed 19 Stock Trades: Benchmark, ON Semi, Semtech and More (Sep-Oct 2026)

· Congress Trades

Rep. Gilbert Cisneros disclosed 19 stock trades, Oct 12, 2026

Rep. Gilbert Cisneros (CA-31) disclosed 19 stock transactions on October 12, 2026, dated September 28 to October 1: 11 purchases, 7 sales and 1 exchange, with the largest lines in the $15,001–$50,000 band.

Trade data: Bargo, compiled from U.S. House and Senate STOCK Act filings.

DateTickerCompanyType / sizePrice at trade vs. Nov 6 (Bargo est.)
Oct 1THRThermon Group Holdings, Inc.Exchange, $15,001–$50,000not provided
Sep 29AEISAdvanced Energy Industries, Inc.Purchase, $1,001–$15,000$283.30 vs. $197.01 (−30.46%)
Sep 29ALGMAllegro MicroSystems, Inc.Purchase, $1,001–$15,000$36.60 vs. $28.17 (−23.03%)
Sep 29ALKSAlkermes plcPurchase, $1,001–$15,000$40.80 vs. $45.90 (+12.50%)
Oct 1BHEBenchmark Electronics, Inc.Purchase, $15,001–$50,000$84.62 vs. $60.40 (−28.62%)
Sep 29CYTKCytokinetics, IncorporatedPurchase, $1,001–$15,000$65.64 vs. $53.69 (−18.21%)
Sep 29GTESGates Industrial Corporation Ltd. Common SharesPurchase, $1,001–$15,000$26.64 vs. $24.10 (−9.53%)
Sep 28ONON Semiconductor CorporationPurchase, $15,001–$50,000$75.65 vs. $63.31 (−16.31%)
Sep 29PRAXPraxis Precision Medicines, Inc.Purchase, $1,001–$15,000$281.00 vs. $277.62 (−1.20%)
Sep 29RAREUltragenyx Pharmaceutical Inc.Purchase, $1,001–$15,000$15.32 vs. $15.43 (+0.72%)
Sep 29TNDMTandem Diabetes Care, Inc.Purchase, $1,001–$15,000$16.57 vs. $16.91 (+2.05%)
Sep 29YETIYETI Holdings, Inc.Purchase, $1,001–$15,000$42.55 vs. $44.97 (+5.69%)
Sep 29ATRCAtriCure, Inc.Sale, $1,001–$15,000$58.05 vs. $58.54 (+0.84%)
Sep 29BBIOBridgeBio Pharma, Inc.Sale, $1,001–$15,000$65.97 vs. $74.29 (+12.61%)
Sep 29HALOHalozyme Therapeutics, Inc.Sale, $1,001–$15,000$111.56 vs. $103.63 (−7.11%)
Sep 29ITTITT Inc.Sale, $15,001–$50,000$204.54 vs. $205.55 (+0.49%)
Sep 29MTSIMACOM Technology Solutions Holdings, Inc.Sale, $15,001–$50,000$284.27 vs. $210.98 (−25.78%)
Sep 29OXMOxford Industries, Inc.Sale, $1,001–$15,000$25.01 vs. $29.35 (+17.35%)
Sep 29SMTCSemtech CorporationSale, $1,001–$15,000$180.10 vs. $103.21 (−42.69%)

Transaction dates: Sep 28 to Oct 1, 2026. Disclosure date: Oct 12, 2026 (11 to 14 days later). Member: Rep. Gilbert Cisneros, CA-31 (House). Bargo gives no price estimate for the Thermon (THR) exchange line.

What's been disclosed

  • 11 purchases: including Benchmark Electronics (BHE) and ON Semiconductor (ON) in the $15,001–$50,000 band, plus Advanced Energy (AEIS), Allegro MicroSystems (ALGM), Cytokinetics (CYTK), Gates Industrial (GTES), YETI, Tandem Diabetes (TNDM), Ultragenyx (RARE), Praxis Precision (PRAX) and Alkermes (ALKS) at $1,001–$15,000.
  • 7 sales: MACOM (MTSI) and ITT in the $15,001–$50,000 band, plus Semtech (SMTC), Oxford Industries (OXM), Halozyme (HALO), BridgeBio (BBIO) and AtriCure (ATRC) at $1,001–$15,000.
  • One exchange: Thermon Group (THR), $15,001–$50,000, on October 1.
  • Price since: Bargo's estimate puts Benchmark Electronics about 28.6% lower on November 6 than on October 1, Advanced Energy about 30.5% lower and Allegro MicroSystems about 23.0% lower than on September 29. Semtech, which was sold, is about 42.7% lower than at the sale date.
  • Timing: the filing came 11 to 14 days after the trades, inside the 45-day window.

Quick FAQ

How long after the trades were they disclosed?
11 to 14 days after the trades, which were dated September 28 to October 1. The STOCK Act gives members 45 days from the transaction to disclose it.

Why are the amounts ranges?
Filings report value bands such as $15,001–$50,000 instead of exact dollar amounts.

Where does the price comparison come from?
It is Bargo's estimate, comparing the price on the transaction date with the November 6 price. It is not the member's actual execution price.

What does "exchange" mean in a filing?
It is a transaction type listed separately from a purchase or a sale; the data Bargo carries does not explain it further.

Trade data from Bargo (STOCK Act filings). This post is our own summary of public filings and is not investment advice. See our Disclaimer and evidence labels.
Stock Anatomy · Last checked: November 9, 2026

Related